☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Varenicline reviewed by Cochrane Library

The Cochrane Library has published a review of the evidence supporting nicotine receptor partial agonists including varenicline.

The authors conclude that varenicline is three times more effective than placebo in achieving successful long-term smoking cessation and is more effective than bupropion based on the currently published trial data. They also highlight the need for comparative studies with nicotine replacement therapy and independent trials of varenicline versus placebo to confirm the findings of industry trial.

Finally, the authors state that the efficacy of varenicline as an aid to relapse prevention has not been clearly established.

Action: Nicotine replacement therapy remains the first line choice. Varenicline (and bupropion) are suitable alternatives where NRT treatment fails. Extended varenicline treatment to prevent relapse cannot be recommended until efficacy has been more clearly established.

Share 'Varenicline reviewed by Cochrane Library' by emailShare 'Varenicline reviewed by Cochrane Library' on FacebookShare 'Varenicline reviewed by Cochrane Library' on TwitterShare 'Varenicline reviewed by Cochrane Library' on LinkedInShare 'Varenicline reviewed by Cochrane Library' on reddit


One Comment to “Varenicline reviewed by Cochrane Library”

  1. Nicotine is one of the most addicting substance in this world so avoid smoking cigarettes.

    Comment by Reece Khan — May 18, 2010 #

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.